Berkeley Lights, Inc.
5858 Horton Street
Suite 320
Emeryville
California
94608
United States
86 articles about Berkeley Lights, Inc.
-
Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company
3/21/2023
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today announced that it has completed its previously announced acquisition of IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome.
-
Berkeley Lights Reports Fourth Quarter and Full Year 2022 Financial Results
2/23/2023
Berkeley Lights, Inc. (Nasdaq: BLI), a life sciences tools company, today reported financial results for the fourth quarter and full year ended December 31, 2022.
-
Berkeley Lights to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
2/13/2023
Berkeley Lights, Inc., a life sciences tools company, announced that the Company will be reporting financial results for the fourth quarter and full year 2022 after market on Thursday, February 23, 2023.
-
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
1/9/2023
Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development.
-
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
1/3/2023
Berkeley Lights, Inc., a life sciences tools company, announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.
-
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
12/21/2022
Berkeley Lights and IsoPlexis announced a definitive agreement under which Berkeley Lights will acquire IsoPlexis in an all-stock transaction valued at $57.8 million.
-
Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow
11/18/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced the launch of the Opto® Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon® platform.
-
Berkeley Lights Reports Third Quarter 2022 Financial Results
11/8/2022
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended September 30, 2022.
-
Berkeley Lights to Report Third Quarter 2022 Financial Results on November 8, 2022
10/18/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced that the Company will be reporting financial results for the third quarter 2022 after market on Tuesday, November 8, 2022.
-
Berkeley Lights to Participate in the BioProcess International 2022 Conference
9/21/2022
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the Bioprocess International 2022 Conference (BPI) being held from September 27 - 30, 2022, at the Boston Convention and Exhibition Center.
-
Berkeley Lights Announces Appointment of Scott Chaplin as Chief Legal Officer
9/19/2022
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Scott Chaplin has been named the Company's chief legal officer and corporate secretary, effective immediately.
-
Berkeley Lights Reports Second Quarter 2022 Financial Results
8/9/2022
Berkeley Lights, Inc., a leader in digital cell biology, reported financial results for the quarter ended June 30, 2022.
-
Berkeley Lights to Participate in the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit Conference
8/3/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced its participation at the Cambridge Healthtech Institute's 14th Annual Bioprocessing Summit being held from August 15 - 18, 2022, virtually and at the Sheraton Boston in Boston, Massachusetts.
-
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide
7/27/2022
Berkeley Lights, Inc. and Aanika Biosciences today announced that the companies have successfully reached their strategic partnership milestone by identifying a commercially viable antimicrobial peptide (AMP) to enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of food borne illness related recalls.
-
Berkeley Lights Announces Mehul Joshi as New Chief Financial Officer
7/25/2022
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately.
-
Berkeley Lights to Report Second Quarter 2022 Financial Results on August 9, 2022
7/21/2022
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the second quarter 2022 after market on Tuesday, August 9, 2022.
-
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
6/22/2022
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal.
-
Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities
6/6/2022
Berkeley Lights, Inc., a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization, announced Curia’s adoption of The Beacon® Optofluidic system and workflows from Berkeley Lights to accelerate and expand its antibody-based drug discovery capabilities.
-
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022
4/26/2022
Berkeley Lights, Inc., a leader in digital cell biology, announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022.
-
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer
3/9/2022
Berkeley Lights, Inc. a leader in digital cell biology, announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer, effective immediately.